Market Overview The Waldenstrom macroglobulinemia market is personalizing as precision diagnostics enable tailored B-cell malignancy care based on molecular characterization. The Waldenstrom Macroglobulinemia Market is projected to grow through 2036, driven by MYD88 mutation routine testing, CXCR4 status assessment, genomic profiling expansion, and biomarker-guided therapy selection improving...